Oral candidoses are frequently encountered in the practice of dentistry.
O R A L M E D I C I N E
ral candidosis is a collective term for the group of diseases that result from infection with Candida spp., affecting both immunocompetent and immunocompromised individuals. (The terms 'candidosis' and 'candidiasis' are synonymous: candidosis will be used throughout this article.) Non-candidal oral mycoses (cryptococcosis, histoplasmosis and geotrichosis) are extremely rare and generally diagnosed only in HIV-infected individuals. 1 The effects of oral candidosis may range from localized infections to acute, systemic disseminated disease. Oral candidoses are often symptomless and can be a marker of underlying immunosuppression, and are therefore referred to as the 'diseases of the diseased'. Immunosuppression is an important consideration for any candidosis that either does not resolve rapidly with appropriate conventional management, or recurs frequently.
Oral candidal species can be identified as part of the oral commensal flora in 41% of the 'normal' population, 2 and it is impossible to eradicate Candida from the oral cavity completely. Candida spp. are opportunistic pathogens, resulting in disease when the host-commensal relationship is disturbed. Candida albicans is the species most often cultured from candidoses in immunocompetent individuals; however, the non-albicans spp. are more frequently isolated from oral candidoses in the immunocompromised patient, and in such individuals the course of oral candidosis can be protracted and resistant to normal management protocols.
Organisms Involved in Oral Candidosis
Although C. albicans is frequently identified in the aetiopathogenesis of candidosis, other candidal species can be isolated from oral candidal lesions: ! C. tropicalis; ! C. pseudotropicalis; ! C. glabrata; ! C. krusei; ! C. parapsilosis.
PREDISPOSING FACTORS
A number of predisposing factors have been identified, all with the common feature of producing a change in the hostcommensal balance (altered oral homeostasis), allowing the proliferation of the candidal organisms that results in candidosis. C. albicans normally coexists with Lactobacillus acidophilus in the vegetative (yeast or blastospore) state; however, it can readily change to the elongated cellular form (pseudohyphae) or chlamydospore forms. C. albicans has weak pathogenicity and when an imbalance occurs in the host-commensal relationship this commensal organism has the opportunity to become pathogenic. The production of an endotoxin -an extracellular proteolytic enzyme -is responsible for most of the adverse effects of the intraoral mucous membrane in oral candidosis.
Predisposing localized and systemic factors can be classified as natural factors, dietary factors, mechanical factors and iatrogenic factors or grouped according to physiological factors, trauma, dietary factors, endocrine factors, malignancy, immune defects, xerostomia, disturbed oral flora and 'other' factors. Table 1 summarizes the predisposing factors in oral candidosis.
The physiological factors -the extremes of age -predispose to oral candidosis, as they are associated with an impaired host response.
Mechanical irritation (from acrylic dentures and orthodontic appliances) may result in the breakdown of the integrity of the mucous membrane, destroying its intrinsic antimicrobial resistance, 3 while the close contact of the acrylic and mucous membrane prevents salivary antimicrobial substances (lysozyme, lactoferrin, the lactoperoxidase system and salivary glycoproteins) coming into contact with the invading microorganisms.
Some dietary factors such as a high carbohydrate intake provide Candida spp. with ideal metabolites, whereas the deficiency states (iron, vitamin B 12 and folate) may reflect the poor resistance of the intraoral and perioral tissues to infection by Candida spp.
Endocrine disturbances, the presence of malignancy and immune defects (e.g. AIDS) are associated with an inferior host response, particularly cell-mediated immunity. Furthermore, areas of ulcerated mucous membrane associated with oral carcinomata predispose to oral candidosis. The therapeutic use of chemotherapy and radiotherapy in malignancy are associated with an increased risk of oral candidosis: the mechanisms are complex, but involve these therapies having a direct effect on the rate of cellular turnover in the oral mucous membrane and reducing the salivary flow, respectively. Oral candidosis may be one of the earliest signs of AIDS, and in HIV-infected patients candidoses can affect multiple intraoral sites. 1 Xerostomia results in reduced flow and quality of saliva and predisposes to oral candidosis. The reduced effectiveness of the antimicrobial properties of saliva (lysozyme, lactoferrin, the lactoperoxidase system, and salivary glycoprotein 4 ) favours the proliferation of Candida spp.
Broad-spectrum antibiotics, steroid aerosols and smoking interfere with the normal balance of the oral microbial flora by removing the competition between the various microorganisms for adherence and nutrition which, in health, limits the growth and dissemination of fungi. Hospitalization may predispose individuals to oral candidosis; patients in hospital may encounter microorganisms to which they cannot mount an effective immune response, either because of reduced immunocompetence as a result of ill-health or due to the exposure to previously unmet potential pathogens.
Following the discovery of a predisposing factor in a patient diagnosed with oral candidosis, its rectification should form an integral component of the overall patient management: the failure either to identify or manage predisposing factors will prevent the expedient resolution of oral candidosis, and will most likely result in recurrence. Where it is not possible to eliminate predisposing factors, such as in the long-term use of inhaled steroids or where malignancy is present, the prophylactic prescription of an antifungal agent may prevent recurrence.
Immunocompromization is the single most important predisposing factor that should be considered in patients with oral candidosis, owing to the potential for significant general health sequelae and, in severe cases of immunosuppression, the patient's immune response may become overwhelmed by systemic candidosis, leading to a life-threatening situation. The prophylactic prescription of an antifungal may not only improve life quality, but also life expectancy for the severely immunocompromised patient.
CLASSIFICATION OF ORAL CANDIDAL CONDITIONS
The first classification of oral candidosis was proposed by Lehner 
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is based upon clinically relevant terminology and accounts for the limitations of Lehner's original classification (see Table 2 ). As pseudomembranous candidosis can be present for an extended period of time, particularly in immunocompromised patients or in those using inhaled steroids, 'pseudomembranous' should be prefixed with 'acute' or 'chronic' as appropriate. 6 The term 'erythematous' represents a more valid term than 'atrophic' for lesions that appear more 'red' than the surrounding mucous membrane, as redness of the mucous membrane may be due to either atrophy or increased vascularity.
As angular cheilitis and denture stomatitis and median rhomboid glossitis may have a combined bacterial and fungal aetiology, they are more appropriately classified as Candidaassociated lesions.
PSEUDOMEMBRANOUS CANDIDOSIS
This condition (see Figure 1 ) is also known colloquially as 'thrush'. The clinical lesions of pseudomembranous candidosis are very characteristic. Nonadherent creamy white patches or flecks are easily wiped from an underlying erythematous and bleeding mucous membrane. Commonly affected areas are the soft palate, oropharynx, tongue, cheek and gingivae. Surprisingly, pain is rarely reported.
The pseudomembrane consists of a mesh of fungal hyphae containing entangled desquamated epithelial cells, fibrin, keratin, necrotic tissue and bacteria. Although pseudomembranous candidosis is usually termed 'acute' in view of the short duration of the condition, in immunocompromised individuals the condition is often of a chronic, protracted nature, and can last for months (and even years).
Diagnosis
The diagnosis of pseudomembranous candidosis can usually be based on the clinical findings, although a swab of the lesion should be sent for culture and sensitivity, and a phosphate-buffered saline rinse may indicate the fungal load present within the patient's mouth (Table  3) . A smear may also be helpful in the diagnosis of pseudomembranous candidosis; however, biopsy is not usually necessary. The identification of the causative candidal species and any resistance to proposed antifungal agents will allow the clinician to provide effective patient management.
Management
Pseudomembranous candidosis in the immunocompetent patient is usually managed using topical agents alone, although use of systemic agents may be associated with increased compliance because nystatin pastilles and amphotericin B lozenges have an unpleasant taste (Table 4 ). In patients with AIDS, systemic antifungals are more effective than topical agents.
Patients who do not experience resolution of pseudomembranous candidosis within two weeks of the institution of antifungal therapy should be referred for investigation of possible underlying disease. Pseudomembranous candidosis in the immunosuppressed (e.g. AIDS) should be managed in specialist centres.
ERYTHEMATOUS CANDIDOSIS
Erythematous candidosis may be termed 'acute' or 'chronic', depending on the time factor in the course of the condition. The acute form was formerly known as 'acute atrophic candidosis', 'antibiotic sore tongue' or 'glossodynia' and is now known as erythematous candidosis. It often results from treatment with broadspectrum antibiotics, steroid preparations (e.g. asthma inhalers), and short-course topical antibiotics. The tongue is most often affected, although any area of the oral mucous membrane is susceptible. Erythematous candidosis resulting from the prescription of broad-spectrum antibiotics is the only oral candidosis where pain is a common symptom.
Diagnosis
The clinical diagnosis of erythematous candidosis may be confirmed by microbiological analysis of the organisms cultured from a swab of the lesion, and a phosphate-buffered saline rinse may indicate the intraoral fungal load (see Table 3 ). A biopsy provides no additional diagnostic value.
Management
Cessation of treatment with the offending antibiotic medication usually leads to spontaneous resolution: however, this may not be possible and topical antifungals may be necessary prophylactically if the causative therapy is to be continued (Table 4) .
Patients using inhaled steroid prescriptions should be advised to rinse their mouth after inhalation to ensure speedy resolution of erythematous candidosis. Moreover, routine oral rinsing after inhalation should be suggested as a preventive measure to all people using inhaled steroid prescriptions.
HYPERPLASTIC CANDIDOSIS
This chronic condition is also known as candidal leukoplakia and is characterized by irregular whitish raised plaque-like lesions on the buccal mucous membrane near to the commissures (see Figures 2 and 3) . The tongue is rarely involved. The patient and referring dentist are often concerned about potential malignancy (Figure 3 ). Lesions are usually bilateral, do not have a surface that is easily removed, and can be extensive. Most patients are smokers. Other candidal lesions may also be present, possibly angular cheilitis.
Diagnosis
Biopsy may be considered appropriate in certain cases to exclude neoplasia ( (Table 3) .
Management
The condition is managed by rectification of any predisposing factors (e.g. smoking), provision of an appropriate antifungal (either topically or systemically) and by institution of a low-carbohydrate diet (see Table 4 
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combined and lengthy treatment. Follow up is imperative to ensure complete resolution, and for persistent lesions cryosurgery or surgical excision should be considered unless precluded by the size of the lesion.
CANDIDA-ASSOCIATED DENTURE-INDUCED STOMATITIS
This condition is classified as a Candida-associated lesion, as it may result from a combined bacterial/fungal aetiology. Patients affected by Candida-associated, denture-induced stomatitis are not usually aware of its presence. Curiously, in full-denture wearers, the maxillary denture-bearing area is more often affected than the mandibular denture-bearing area. 
Diagnosis
The appropriate investigations for Candida-associated, denture-induced stomatitis are outlined in Table 3 . A swab of the lesions, the fitting surface(s) of dentures and orthodontic appliances should be sent for culture and sensitivity, while a phosphatebuffered saline oral rinse will indicate the intraoral fungal load. Blood tests form an essential part of the management of this condition, in order to identify any predisposing factors, which include the deficiency states (iron, vitamin B 12 , folate) and possible undiagnosed diabetes mellitus. A biopsy specimen provides no additional diagnostic information.
Management
The management of the condition should follow the following lines:
1. Correction of any predisposing factors. 2. Improved appliance hygiene:
immersion of the appliance in a 1% hypochlorite solution for acrylic appliances, or 2% chlorhexidine solution for metal-based dentures, whilst sleeping. 3. Advice regarding a lowcarbohydrate diet.
Prescription of antifungals.
Miconazole oral gel should be applied to the fitting surface of the appliance and the denture-bearing area four times daily (the antifungal is most effective while the patient is sleeping due to the reduced salivary flow). Miconazole is available over the counter as well as on prescription, but should be avoided by patients concurrently being prescribed oral anticoagulants. A 2% chlorhexidine mouthwash can also be of benefit due to its antifungal action. 5. Systemic antifungal agents (see Table 4 ) may be considered for patients whose compliance may be expected to be poor (such as elderly people in care), immunocompromised patients and for patients with Newton's Type 3 Candida-associated dentureinduced stomatitis (in addition to the application of miconazole oral gel to the palate and the fitting surface of the denture).
ANGULAR CHEILITIS
Angular cheilitis presents as erythema and crusting of the skin at the commissures of the lips ( Figure 5 ). As a mixed bacterial/fungal aetiology may be present, it should be classified as a Candida-associated lesion. Edentulous elderly people are most commonly affected by angular cheilitis. In most cases of angular cheilitis, simultaneous intraoral candidosis is evident. A multifactorial aetiology has been proposed for this disease and includes:
! infection by either Candida spp. or Staphylococcus spp. (sometimes both); ! deficiency states: notably iron, vitamin B 12 and folate deficiency (these may also be identified in the anaemias and latent anaemias); ! undiagnosed or poorly controlled diabetes mellitus; ! skin creasing due to advancing age; ! poor dentures with inadequate vertical component, allowing the skin at the commissures to crease 
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and retain saliva; ! systemic disorders, e.g. diabetes mellitus, HIV infection.
Diagnosis
Haematological investigations are important to exclude deficiency disease (ferritin, vitamin B 12 , folate); importantly, a blood glucose assay may highlight possible undiagnosed diabetes mellitus, which may be a significant predisposing factor. Swabs of the commissures and the anterior nares, and any potential intraoral reservoir for organisms (commonly the fitting surface of dentures, the palate and areas of hyperplastic candidosis) should also be sampled. These samples are important to identify the causative organism as well as the nucleus of organisms, which may be 'feeding' the angular cheilitis.
A phosphate-buffered saline oral rinse should also be undertaken. This may detect the presence of Candida at intraoral sites not otherwise sampled.
Management
The management of angular cheilitis (see Table 4 ) will depend on the elimination of organisms from the reservoir of infection and the treatment of any systemic sources of microorganisms. The empirical application of miconazole gel four times daily to the lesions is helpful, as it is active against both Candida spp. and Staphylococcus spp., as well as other Gram-positive organisms; and therefore will eliminate many cases of infection. An alternative is fusidic acid (Fucidin), again applied four times daily to the lesions, but this is generally only prescribed on the basis of a confirmatory microbiological report exclusively identifying Staphyloccus spp. as the causative organism.
If microbiology reveals an intraoral source of infection (commonly the fitting surface of a denture and palate) this must also be treated appropriately. Similarly, if organisms are identified in the anterior nares, they must also be treated.
The concomitant prescription of topical and systemic antifungals for angular cheilitis (where intraoral and/or intranasal reservoirs have been identified) may be regarded as a 'belt and braces' approach but should ensure speedy resolution. Systemic antifungals are the treatment of choice for angular cheilitis in immunocompromised individuals, for lesions resistant to topical measures alone, and where compliance is likely to be poor.
The failure to identify or treat a reservoir of organisms will result in the angular cheilitis recurring. Sufferers should be discouraged from any habits that involve contact of nose and mouth in close succession. Fabrication of new full dentures should be delayed until angular cheilitis has resolved.
MEDIAN RHOMBOID GLOSSITIS
The usual clinical manifestation of median rhomboid glossitis is of a diamond-shaped depapillated erythematous patch on the midline of the tongue dorsum ( Figure 6 ). It is classified as a Candida-associated lesion as a mixed microbiological flora may be implicated in the aetiology.
Diagnosis
The diagnosis is usually clinically based; however, a swab and a phosphate-buffered saline oral rinse should be carried out, as a mixed aetiological flora may be identified. Biopsy is unnecessary, unless diagnostic uncertainty still exists following the microbiological investigations and the lesion fails to respond to antifungal agents.
Management
Treatment requires the prescription of topical or systemic antifungals. However, Nystatin and amphotericin B are not palatable, and compliance may be poor, in which case systemic antifungals may be more effective (Table 4) . Advice regarding cessation of smoking is an integral part of the management of patients with median rhomboid glossitis, in order to prevent successive recurrences.
OTHER CONDITIONS
These include cheilocandidosis, mucocutaneous candidosis and chronic oral multifocal candidosis. The reader is referred to a specialist text for further information.
LABORATORY INVESTIGATIONS FOR ORAL CANDIDOSIS
The most appropriate laboratory investigations are outlined in Table 3 .
Swabs, first moistened with sterile saline and then rubbed along the surface of the lesions, should be promptly submitted to the microbiological laboratory with a request for culture and sensitivity. These allow the identification of the causative candidal species, which in most cases is C. albicans. However, the identification of non-albicans Candida spp. is of considerable relevance in the management of oral candidosis -especially in the immunocompromised patient -as nonalbicans organisms may not respond to common topical and systemic antifungals.
A smear of the lesion may duplicate the information provided by a swab but in cases of diagnostic uncertainty, may be indicated.
A phosphate-buffered saline oral rinse will determine the presence of Candida within the oral cavity; and high candidal counts correspond with high fungal loads in the diseased areas of mucous membrane.
Biopsy is generally unnecessary for the diagnosis of oral candidosis, except where potential malignancy is one of the provisional diagnoses.
Blood investigations should be instigated where appropriate, in order to identify any deficiency states and undiagnosed or poorly controlled diabetes mellitus, which may indicate poor tissue resistance to candidal infection. This multi-author text aims to provide an up-to-date account of the pathogenesis and management of oral cancer. It embraces the basic science, pathology and clinical aspects of this disease.
Contemporary Issues in
No fewer than 29 authors have contributed to this book, which comprises 17 chapters and runs to some 405 pages in length. Ten of the contributors work at the Tata Memorial Centre and thus it is not surprising that the text is biased somewhat towards the issue of oral cancer in South Asia.
The first chapter addresses the epidemiology and possible prevention of oral cancer, introducing the subject matter effectively, whilst chapter two provides an overview of the molecular biology of the disease. This is an intrinsically complex topic and, in parts, the grammatical style of the text does not encourage the reader's grasp of the subject matter.
The following three chapters outline immunological aspects of oral cancer.
The text continues with chapters on serological markers in head and neck malignancy, the possible aetiological role of viruses and a chapter devoted to chemoprevention.
Six chapters address therapeutic modalities of oral cancer and, as well as summarizing the more traditional approaches, the potential use of photodynamic therapy, immunotherapy and gene therapy are also discussed.
The book concludes with a discussion of novel diagnostic techniques and finally summarizes certain of the more recent observations in the field of oral malignancy, considering their possible future applications in the management of this disease.
The work is extensively referenced, but a number of the illustrations lack clarity and are difficult to interpret. There is a widespread and unnecessary use of abbreviations throughout the text. A number of these abbreviations are not in common usage and this may be a source of irritation to the reader.
In summary, this book is very broad in its scope and perhaps, as a result, represents somewhat of a compromise, lacking a particularly authoritative approach. However, it should appeal to both clinicians and basic scientists who either have an interest in, or are involved with, the management of patients with oral cancer. The publication contains a very considerable amount of information and at a cost of £25, notwithstanding some of the above criticisms, it represents good value for money.
John Hamburger Birmingham Dental School
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